<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">

<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" >

   <HEAD>

	<TITLE>Human purine nucleoside phosphorylase enzyme - active PNP enzyme</TITLE>

	<!--[if IE 6]><meta http-equiv="Refresh" content="0; url=http://www.novocib.com/IE7/index.html"><![endif]-->

    <!--[if IE 7]><meta http-equiv="Refresh" content="0; url=http://www.novocib.com/IE7/index.html"><![endif]-->

    <META http-equiv=Content-Type content="text/html; charset=iso-8859-1">

	<META name=Title content="Human active PNP enzyme">

	<META name=Author content="NovoCIB (lbalakireva@novocib.com)">

	<META name=Subject content=">

	<META name=Description content="Human Recombinant PNP">

	<META name=Keywords content="buy PNP, Purine Nucleoside Phosphorylase, PNP, E.C.2.4.2.1, purine salvage, purine metabolism, PNP deficiency, inosine, guanosine, phosphorolysis, Forodesine, BCX-1777, T-cell lymphoma, chronic lymphocytic leukaemia, CLL"> 

	<META content=en name=Language>

	<META content=" name=Expires>

	<META content="NOVOCIB � 2006" name=Distribution>

	<META content=All name=Robots>

	   <!-- css -->

	   <LINK href="css/Stylesmaller.css" type=text/css rel=stylesheet>

	   <!-- favico -->

	   <LINK href="http://www.novocib.com/favicon.ico" rel="shortcut icon">

	   <link rel="stylesheet" media="screen" type="text/css" title="Style" href="css/Stylesmaller.css">

<!-- end favico -->



<!-- script du menu -->

<script type="text/javascript" src="JavMenu.js"></script>

 <!-- d�t�ction du navigateur -->

<script type="text/javascript" src="navdetecteur.js"></script>



<!-- important pour que les vieux navigateurs ne comprennent pas le CSS -->

<style type="text/css">

    @import "Stylesmaller.css";

</style>



</head>

<body>

<div id="page">



<!--[if lt IE 8]><div align=left class="smallRed">This site is designed for IE 8 or IE 9. We are working for compatibility with lower versions. For better convenience, please visit us with IE 8, IE 9, Google Chrome or Firefox, or any other compatible navigator</div><![endif]-->



<!-- HEADER -->

<div id="header">

  <div id="headerLogo"><a href="/" title="novocib home page"><img src="images/logo NovoCIB1.png" width="247" height="122"/></a></div>

    <p>&nbsp;

     </script>

<script src="//platform.linkedin.com/in.js" type="text/javascript">

 lang: en_US

</script>

<script type="IN/FollowCompany" data-id="5048147" data-counter="none"></script>

    <div id="headerSlogan"><SPAN class=ChapterThirdTitle><em>Reliable solutions for nucleotide assessment</em></SPAN><img src="images/HorizBarMenu.gif" width=380 /></div>

<div><a href="mailto:contact@novocib.com?subject=Contact" class="MenuContact" title="Contact">Contact</a>&nbsp;&nbsp;</div> <br /><br />

</div>

<!-- End HEADER -->



<!-- SQUARE RIGHT -->

<div id="SquareRight" class="small">

  

  <div align="center" class=ChapterThirdTitle style4>Award</div>

  <div align=center>Dr Larissa Balakireva, CEO &amp; Founder of NovoCIB, was awarded with the Trophy of

      <br /><a href="http://www.aufeminin.com/evenement/femmes-en-or/" Title="Femmes en Or 2011" class="boldRedAct" target=_blank>"Femmes en Or 2011, Femme de l'Innovation"</a>

      <br />in September 2011

  </div>.

  <div align=center><a href="http://www.aufeminin.com/evenement/femmes-en-or/" Title="Femmes en Or 2011" class="boldRedAct" target=_blank><img src="images/trophees femmes en or.jpg"/ width=100 ></a>

  </div>

  

    

</div>

<!-- End SQUARE RIGHT -->







<!-- MENU PRINCIPAL, HORIZONTAL -->

<div id="menu">

  <ul id="MenuDeroul">

    <li><a href="Purified_Active_Enzymes.html"><strong>PURIFIED<br />

    ENZYMES</strong></a>

        <ul>

            <li><a href="Recombinant_Purine_Metabolism_Enzymes.html">Purine Metabolism Enzymes</a>

                <ul>

                    <li><a href="IMPDH_Recombinant_Enzyme.html">IMPDH Enzymes<br /><span class="ItemNameHoriz">Inosine Monophosphate Dehydrogenase</span></a>

                        <ul>

                            <li><a href="Human_Recombinant_IMPDH.html">Human IMPDH</a></li>

                            <li><a href="Bacterial_Recombinant_IMPDH.html">Bacterial IMPDH</a></li>

                        </ul>

                    </li>

                    <li><a href="Human_Recombinant_PNP.html">PNP Enzyme<br /><span class=ItemNameHoriz>Purine Nucleoside Phosphorylase</span></a></li>

                     <li><a href="Xanthine_Dehydrogenase_XDH.html">XDH Enzyme<br /><span class=ItemNameHoriz>Xanthine dehydrogenase</span></a></li>

                    <li><a href="Human_Recombinant_HGPRT.html">HGPRT Enzyme<br /><span class=ItemNameHoriz>Hypoxanthine-guanine phosphoribosyltransferase</span></a></li>

                </ul>

            </li>

            <li><a href="Recombinant_Nucleoside_Kinases.html">Nucleoside Kinase  Nucleotidase</a>

                <ul>

                    <li><a href="Recombinant_Adenosine_Kinase.html">ADK Enzyme<br /><span class=ItemNameHoriz>Adenosine Kinase</span></a></li>

                    <li><a href="Recombinant_Deoxycytidine_Kinase.html">dCK Enzyme<br /><span class=ItemNameHoriz>Deoxycytidine Kinase</span></a></li>

                    <li><a href="Recombinant_UMP-CMP_Kinase.html">CMK Enzyme<br /><span class=ItemNameHoriz>UMP-CMP Kinase</span></a></li>

                    <li><a href="Recombinant_5'-nucleotidase.html">cN-II Enzyme<br /><span class=ItemNameHoriz>cytosolic 5'-nucleotidase II</span></a>            </li>

                </ul>

            </li>

            <li><a href="Bacterial_Bioluminescence_Enzymes.html">Bacterial Bioluminescence Enzymes</a>

                <ul>

                    <li><a href="Bacterial_Luciferase.html">Bacterial Luciferase, Highly Pure<br /><span class="ItemNameHoriz">from <em>Photobacterium phosphoreum</em></span></a></li>

                    <li><a href="Bacterial_FMN_Reductase.html">FMN Reductase<br /><span class="ItemNameHoriz">for Bacterial Bioluminescence</span></a>            </li>

                </ul>

            </li>

      </ul>

    </li>

    <li><a href="Nucleotides_Life_Science.html"><strong>NUCLEOTIDES<br /> 

      LIFE SCIENCE<br />

    </strong></a>	

        <ul>

          <li><a href="Convenient_Assay_Kits.html">Assay Kits</a>

          <li><a href="Cellular_Nucleotides_Analysis.html">HPLC Analysis</a>

  </ul>

   <li><a href="Freshness_Assay_Kits.html"><strong>NUCLEOTIDES<br />

      FRESHNESS</strong></a>

       <ul>

              <li><a href="Freshness_Principle.html">Kit Principle</a>

             <li><a href="Freshness_Protocol.html">How It Works</a>

             <li><a href="Case_Studies.html">Case Studies</a>

            <ul><li><a href="Fish_Freshness.html">Fish</a>

             <li><a href="Meat_Freshness.html">Meat</a>    

              </ul></li></ul>

    </li>

    <li><a href="Nucleotide_Analysis_Services.html"><strong>DIETARY<br />

      NUCLEOTIDES</strong></a>

      <ul> 

           

             <li><a href="Yeast_Extract_Nucleotide_Analysis.html">Yeast Extract</a></li>

            <li><a href="Infant_Formula_Nucleotide_Analysis.html">Infant Formula</a></li>

            <li><a href="Aquaculture_Nucleotide_Analysis.html">Aquaculture Feed</a></li>

            <li><a href="Feed_Nucleotide_Analysis.html">Feed &amp; Pet Food</a></li>

            <li><a href="By-Products_Nucleotides.html">By-Products Valorisation</a></li> 

            </ul>

      </li>

    <li><a href="ATP_Breakdown_Assay_Kit.html"><strong>SLAUGHTER<br />

      NUCLEOTIDES<br />

    </strong></a>	

        <ul>

        <li><a href="ATP_breakdown_salmon.html">Fish </a></li>

        <li><a href="Meat_Freshness.html">Meat</a></li>

        </ul>

    </li>

  </ul>



</div>



<!-- End MENU PRINCIPAL, HORIZONTAL -->







<!-- Sub Menu, Vertical -->

<!-- End Sub Menu, Vertical -->



<br />

<!-- Tax Credit announcement -->

<!-- End Tax Credit announcement -->





<!-- page content -->

   

<div id="content" class="default">

  

  <div align="justify"> 

    <!-- Intro -->

    <table width=640>

        <tr><td><table width="250" id="ProductPicture">

                    <tr><td colspan=2 align=center class="zoomWidthW350-450"><p><img src="images/PNP reaction.png" width=350/><br />

                  <br/><span align=right class="ChapterThirdTitle">Human PNP </span><br /><span class="big14bold">Ref. #E-Nov2</span>

                        </td>

                    </tr>

                    <tr><td align=left><strong>Quantity</strong>

                        </td>

                        <td align=right><strong>Price*</strong>

                        </td>

                    </tr>

                    <tr>

                      <td align=left><strong>20 Units</strong></td>

                        <td align=right><strong>&euro; 195.00</strong>

                        </td>

                    </tr>

                    <tr>

                      <td align=left><strong>40 Units</strong>

              </td>

                        <td align=right><strong>&euro; 350.00</strong>

                        </td>

                    </tr>

                    <tr>

                      <td align=left><strong>120  Units</strong>

                  </td>

                        <td align=right><strong>&euro; 780.00</strong></td>

                     </tr>

          <tr>

        <td colspan=2><p><span class="small">* Pricing updated September 7<sup>th</sup>, 2015</span><p>Provided in stable lyophilized form and <span class="defaultBlue"><strong>shipped without dry ice</strong></span><br />

                <strong>To buy human PNP enzyme <a href="mailto:contact@novocib.com?subject=PNP%20Enzyme%20Order" class="boldRedAct" title="PNP Enzyme Order">click here</a> or</strong>

                <strong>ask for</strong> <a href="mailto:contact@novocib.com?subject=PNP%20Enzyme%20quotation%20request" class="TabServRed" title="PNP enzyme quotation">Quotation</a>

          </table>

                <p><span align=right class="ChapterThirdTitle">Human PNP (EC 2.4.2.1) </span></p>

                <p><br /><strong>NOVO</strong><span class="boldRed">CIB</span>'s PNP is a pure and active human  Purine Nucleoside Phosphorylase expressed in <em>E. coli</em>. It has an apparent molecular weight of 32.12 kDa.      <br /> <br />

                  PNP is an important therapeutic target enzyme. Several PNP inhibitors have been developed to treat cancer, viral infection, and auto-immune diseases.

           PNP is also a drug target for new antiparasitic drugs.<br />

           <br /><br />

            

             For direct and continuous measurement of PNP activity see our <a href="http://www.novocib.com/PNP_Assay_Kit.html" class=TabServRed>PRECICE<sup>�</sup> PNP Assay Kit</a>.

        

                   </p>

            <div class="default">

              <div></div>

            </div></td>

            </td>

        </tr>

        <tr><td colspan=2>

            </td>

        </tr>

    </table>

    <br />

    

    <!-- End Intro -->

  </div>

  

  <br />

  

  <div  id="PrincipalItem">  

    <!-- Human Recombinant PNP - Product description -->

    <br />

      <div class=default>

  <table align=center cellspacing=10 class=medium>

             <tr valign=top>

                 <td><div class="FloatLeft"><img src="images/PNP Gel.png" height=160/></div>

                 </td>

                 <td><strong>Unit Definition:</strong> One unit catalyzes the cleavage of 1.0 &micro;mole of inosine per minute at pH 8 at 25�C.

                     <br /><strong>Purity:</strong> controlled by SDS-PAGE.               </td>

                 <td><strong>Assay condition:</strong> <strong>NOVO<span class="mediumboldRed">CIB</span></strong> has developed a coupled xanthine dehydrogenase (XDH) system to directly monitor PNP phosphorolytic reaction on inosine (IR).

                     <div align=center><img src="images/PNP RBC lysate.jpg" alt="PNP activity in red blood cell lysate" width="259" height="186" /></div>

               </td>

             </tr>

           </table>

           <br />

           <div align=right class=medium>Download this document&nbsp;<a href="images/NovoCIB E-Nov2.pdf" target=_blank class="mediumboldRedAct" title="NovoCIB's PNP">"NovoCIB's Human Recombinant PNP"&nbsp;<img width=20 src="images/pdficon_large.gif" /></a>

           </div>

           <div>

             </p>

    <!-- End Human Recombinant PNP - Product description -->

  </div>

       </div>

  </div>  

  

  <br />

  

  <div id="PrincipalItem">

    <!-- PNP, a multiple-faced enzyme -->

    <p><a name="PNP, a multiple-faced enzyme" class="ChapterThirdTitle">PNP, a multiple-faced enzyme</a>

       <div align=right><a href="#top" class="ReturnToTop">(^Top)</a>

       </div>

       <div class=default><strong>Catalytic activity</strong>

           <br />Purine Nucleoside Phosphorylase (PNP) is involved in salvage pathway of the purine metabolism. PNP catalyzes the cleavage of the glycosidic bond of ribo- or deoxyribonucleosides, in the presence of inorganic phosphate as a second substrate, to generate the purine base and ribose- or deoxyribose-1-phosphate. The reaction is reversible for natural substrates:

           <div align=center><img src="images/PNP reaction.png" width=400/></div>

           <br />

           <strong>Therapeutic potential of PNP inhibitors</strong>

           <br />PNP deficiency leads to T-lymphocytopenia, usually with no apparent effects on B-lymphocyte function. These symptoms suggest possible chemotherapeutic applications of potent inhibitors of PNP, as selective immunosuppressive agents, to treat T-cell leukemias or T-cell-mediated autoimmune diseases, such as lupus erythematosus and rheumatoid arthritis1<span class=medium><sup>(1,2)</sup></span>.

           The decrease in plasma and urine levels of urate is an additional symptom of PNP deficiency. PNP inhibitors may contribute to treat hyperuricemic states, such as secondary or xanthine gout.

           <br />Some PNP inhibitors have undergone clinical trials for the treatment of cutaneous T-cell lymphoma, acute lymphoblastic leukemia (ALL), HIV infections, and psoriasis.

           <br />

           <!-- Compounds Table -->

           <table align=center cellspacing=5>

               <tr>

                   <td valign=top>

                       <div class="FloatRight"><img src="images/BCX-34.png" width=120 /><br /><strong>BCX-34 (Peldesine)</strong>

                       <br /><br /><img src="images/BCX-1777.png" width=120 /><br /><strong>BCX-1777 (Forodesine)</strong>

                       </div>

                       <br />Peldesine (BCX-34) was granted orphan drug status for the treatment of T-cell lymphoma and reached phase III as an immunomodulator for inflammatory autoimmune diseases. It has recently entered clinical trial for HIV infections<span class=medium><sup>(3)</sup></span>.

                       <br /><br /><br />Forodesine (BCX-1777) has US orphan drug status for the treatment of T-cell non-Hodgkin's lymphoma, including cutaneous T-cell lymphoma (CTCL), chronic lymphocytic leukaemia (CLL) and related leukaemias, including T-cell prolymphocytic leukaemia (PLL), adult T-cell leukaemia and hairy cell leukaemia, and for the treatment of acute lymphocytic leukaemia (ALL). Forodesine was also designed Orphan drug in Europe for ALL in December 2006, and for CTCL in February 2007<span class=medium><sup>(4)</sup></span>.

                   </td>

               </tr>

           </table>

           <!-- End Compounds Table -->

           <br />PNP inhibitors are also investigated to prevent the cleavage, and the resulting deactivation of Nucleoside Analogues by PNP.

           <br /><br /><span class=medium>Note: Protozoan parasites are auxotrophic for purine and have their own PNPs which have specific activities and properties that differ from the human PNP. Protozoan parasites PNPs are considered to be reasonable target against infection (<em>e.g.</em> Plasmodium falciparum)<span class=medium><sup>(5)</sup></span></span>.

           <br /><br /><strong>PNP, a threat for therapeutic efficacy of Nucleoside Analogues</strong>

           <br /><em>In vivo</em>, phosphorolysis is highly favoured over purine nucleoside synthesis and is coupled with two additional enzymatic reactions: oxidation of the liberated purine base by xanthine oxidase (XO) and its phosphoribosylation by hypoxanthine-guanine phosphoribosyltransferase (HGPRT)<span class=medium><sup>(6)</sup></span>. Thus, PNP plays a key role in the salvage pathway of the purine metabolism, enabling the cell to utilize purine bases recovered from metabolized purine ribo- and deoxyribonucleosides to synthesize purine nucleotides.

           <br />

           This phosphorolysis reaction of purine nucleosides by PNP has a direct impact on the therapeutic efficacy of Nucleoside Analogues. Antitumour or antiviral nucleoside analogues are likely to be cleaved by PNP before being phosphorylated by the cell nucleoside kinases and converted to the active nucleotide form. For instance, 2',3'-dideoxyguanosine (ddG)<span class=medium><sup>(7)</sup></span>, 9-&beta;-D-arabinofuranosyl guanine (AraG)<span class=medium><sup>(8)</sup></span> as well as one of its prodrug, Nelarabine (Arranon<sup>&reg;</sup>, GSK)<span class=medium><sup>(9)</sup></span>, which is intracellularly converted to AraG by Adenosine deaminase (ADA), are PNP resistant nucleoside analogues, whereas 2',3'-dideoxyinosine (ddI)<span class=medium><sup>(10)</sup></span> is easily cleaved <em>in vivo</em> by PNP.

           <br />Since acyclonucleoside analogues are particularly resistant to cleavage by PNP though phosphorylated by viral thymidine kinases (TK), they are generally considered as excellent candidates as antiviral agents (<em>e.g.</em> aciclovir, ganciclovir)<span class=medium><sup>(11)</sup></span>.

           <br /><br /><span class=medium>Note that Ganciclovir is not only PNP resistant, but is also a PNP inhibitor.</span>

           <br /><br /><strong>PNP, a tool for enzymatic synthesis of Nucleoside Analogues</strong>

           <br />

           The reversible reaction catalyzed by PNP can be favorably exploited to synthesize nucleoside analogues, especially when chemical synthesis is difficult to prepare and/or gives low yields.

           <br />

           <span class="FloatRight"><a href="#top" class="ReturnToTop">(^Top)</a></span>

           <br />

           <!-- Bibliography -->

           <table class=small cellSpacing=0 cellPadding=5 align=center>

		       <tr><td valign=top><img src="images/iconsml.gif" width=100/>

                   </td>

			       <td><p><strong>References (with links to PubMed)</strong><br />

                          1. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17544667" class=smallAct target=_blank title="Go to PubMed">S. Hikishima <em>et al.</em> (2007): Synthesis and biological evaluation of 9-deazaguanine derivatives connected by a linker to difuoromethylene phosphonic acid as multi-substrate analogue inhibitors of PNP <em>Bioorg. Med. Chem. Lett.</em> 17(15) 4173�4177B</a><br />

                          2. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10522701" class=smallAct target=_blank title="Go to PubMed">T. Yokomatsu <em>et al.</em> (1999): Synthesis and biological evaluation of 1,1-difluoro-2-(tetrahydro-3-furanyl)ethylphosphonic acids possessing a N9-purinylmethyl functional group at the ring, a new class of inhibitors for purine nucleoside phosphorylases <em>Bioorg. Med. Chem. Lett.</em> 9(19) 2833-2836</a><br />

                          3. <a href="http://clinicaltrials.gov/ct2/show/NCT00002237" class=smallAct target=_blank title="ClinicalTrials.gov (NIH)">ClinicalTrials.gov (NIH)</a><br />

                          4. <a href="http://www.medscape.com/viewarticle/555215" class=smallAct target=_blank title="Medscape">Medscape</a><br />

                          5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15380335" class=smallAct target=_blank title="Go to PubMed">K. Chaudhary <em>et al.</em> (2006): Toxoplasma gondii Purine Nucleoside Phosphorylase Biochemical Characterization, Inhibitor Profiles, and Comparison with the Plasmodium falciparum Ortholog <em>J. Biol. Chem.</em> 281(35), 25652-25658</a><br />

                          6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11337031" class=smallAct target=_blank title="Go to PubMed">A. Bzowska <em>et al.</em> (2000): Purine nucleoside phosphorylases: properties, functions, and clinical aspects <em>Pharmacol. Ther.</em>  88(3), 349-425</a><br />

                          7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7533664" class=smallAct target=_blank title="Go to PubMed">V. Gandhi <em>et al.</em> (1995): Cytotoxicity, metabolism, and mechanisms of action of 2',2'-difluorodeoxyguanosine in Chinese hamster ovary cells <em>Cancer Res.</em> 55(7), 1517-1524</a><br />

                          8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8350627" class=smallAct target=_blank title="Go to PubMed">L. C. Gravatt <em>et al.</em> (1993): Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T-cells from murine bone marrow: application to an in vivo T-cell leukemia model <em>Leukemia</em> 7(8), 1261-1267</a><br />

                          9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7614470" class=smallAct target=_blank title="Go to PubMed">C. U. Lambe <em>et al.</em> (1995): 6-Amino-6-methoxypurine arabinoside: an agent for T-cell malignancies <em>Cancer Res.</em> 55(15), 3352-3356</a><br />

                          10. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8053921" class=smallAct target=_blank title="Go to PubMed">M. Weibel (1994): Potentiating effect of {2[2[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methyl]phenyl]ethenyl} phosphonic acid (MDL 74,428), a potent inhibitor of purine nucleoside phosphorylase, on the antiretroviral activities of 2',3'-dideoxyinosine combined to ribavirin in mice <em>Biochem. Pharmacol.</em> 48, 245-252</a><br />

                          11. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10454209" class=smallAct target=_blank title="Go to PubMed">D. Shugar (1999): Viral and host-cell protein kinases: enticing antiviral targets, and relevance of nucleoside, and viral thymidine, kinases <em>Pharmacol. Ther.</em> 82(2-3), 315-335</a>

                       </p>

                   </td>

	           </tr>

           </table>

           <!-- End Bibliography -->

           <div align=right class=medium>Download this document&nbsp;<a href="images/NovoCIB PNP, a multiple-faced enzyme.pdf" target=_blank class="mediumboldRedAct" title="PNP, a multiple-faced enzyme">"PNP, a multiple-faced enzyme"&nbsp;<img width=20 src="images/pdficon_large.gif" /></a>

           </div>

       </div>

    </p>

    <!-- End PNP, a multiple-faced enzyme -->

  </div>

  

  <br />

  

  <div align="center">

    <table border=1 cellspacing=1 bordercolor=#cc0000>

        <tr align="center" bgcolor="#FFCC00" bordercolor=#ffffff>

            <td colspan="2"><span class="big16boldBlack">Related Links</span>

            </td>

        </tr>

        <tr align="left" valign=top bordercolor=#f5f5f5>

            <td class="RelatedLinksBullet">&bull; <a href="http://www.novocib.com/Recombinant_Purine_Metabolism_Enzymes.html" class="defaultAct">Purine Metabolism Enzymes</a>

            

            </td>

        </tr>

    </table>

  </div>

</div>

<!-- End page content -->



<!-- Go to Top of Page -->

<div id="GoToTopOfPage"></div>

<!-- End Go to Top of Page -->



</div>

<!-- footer -->

<div class="footer"><br />

<SPAN class="Update">Last Update: 2014/04/18</SPAN><SPAN class="Copyright">&copy; All Right Reserved | Copyright &reg; NovoCIB | L.Balakireva 2022 | </SPAN><a href="http://www.novocib.com/Legal_Notice" class="Legal" valign=top title="Legal Notice">Legal Notice</a>

</div>

<!-- End footer -->




<script type="text/javascript">

    initMenu();

</script>



<script>

  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){

  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),

  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)

  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');



  ga('create', 'UA-47165485-1', 'novocib.com');

  ga('send', 'pageview');



</script>

</body></html>